Molecular Diagnostics

 

Molecular Diagnostics Services

Lab21 provides a comprehensive range of molecular diagnostic services for clinical trials. Available technologies and services include:
  • Real-time PCR (Traditional and Proprietary technology)
  • Bead-based multiplex analysis  
  • Sequence-based analysis
  • DNA and RNA extraction from various tissue types
  • Sample storage for retrospective analysis
Our expert services use gold standard commercial assays or bespoke custom assays developed by Lab21 from initial biomarker identification, from published protocols or by transfer of Client’s technology.

In addition to our clinical trial and research services, Lab21 is an accredited specialist molecular diagnostics testing hub for clinicians and healthcare providers globally.  Please see below for a list of currently available MDx services.  Lab21 will also develop novel and customised assays as requested.

Oncology

Assays already in clinical use:
Additional assays for research use include p53 and c-Kit sequencing and EML4-ALK fusion gene analysis.

HIV

Assays already in clinical use:
Lab21 also provides extensive research services to examine the genetic basis of viral drug resistance.

Viral Hepatitis

Assays already in clinical use:
Lab21 also provides extensive research services to examine the genetic basis of viral drug resistance.

Additional assays for research use include the proprietary HCV drug resistance genotyping including the analysis of genomic sequence variation in the viral serine protease gene, NS3.

Pharmacogenetics

Assays already in clinical use include:  Other assays for research use include: